# gpqa-recoOD3zBJsXtLjBv

Run: gpqa-main-ours-8gpu; arm: ours.

Expected: D
Model answer: B
Scoring outcome: wrong extracted answer; answer source: after_thinking_end.

## Question

A chemist is synthesizing an RNA nucleoside phoshoramidite from a β-D-ribonucleoside.

First, they install the DMTr protecting group on the 5'-OH. Next, they treat the 5’-ODMTr ribonucleoside with 1.1 eq of TBDMSCl; two products are formed (products 1 and 2). They isolate the two products and take the 2D COSY NMR spectrum of each.

Important features of the COSY spectrum of product 1 are: 
*A correlation between a 1H doublet at approx. 6 ppm (Ha) and a 1H doublet-of-doublets at approx. 4.5 ppm (Hb)
*A correlation between Hb and a broad singlet at approx. 5.5 ppm
*A correlation between Hb and another 1H doublet-of-doublets at approx. 4.5 ppm (Hc)

They discard product 2 and take product 1 through to the final nucleoside phosphoramidite by treating it with 2-cyanoethyl N,N-diisopropylchlorophosphoramidite. They then use this phosphoramidite to synthesize an RNA oligo using standard solid-phase methodology.

If they compare their synthetic RNA oligo with a naturally occurring RNA oligo with exactly the same types and sequence of bases, what is the relationship?

(A) Diastereoisomers
(B) Identical
(C) Constitutional isomers, but not regioisomers
(D) Regioisomers

## Final response

```text


The problem involves the synthesis of an RNA nucleoside phosphoramidite from a β-D-ribonucleoside. The key steps and the NMR data provided are critical to understanding the stereochemistry and structure of the final product.

---

### Step-by-Step Reasoning:

1. **Starting Material**: The chemist begins with a **β-D-ribonucleoside**, which is the natural configuration of the ribose sugar in RNA. This means the sugar has the correct stereochemistry for RNA (i.e., the anomeric carbon is in the β configuration, and the 2' OH is present in the equatorial position in the furanose ring).

2. **Protection Steps**:
   - First, the **5'-OH** is protected with **DMTr** (dimethoxytrityl).
   - Then, **TBDMSCl** (tert-butyldimethylsilyl chloride) is added in 1.1 equivalents. This reagent silylates the hydroxyl groups on the ribose sugar.
   - Since the ribose has two free hydroxyls (2' and 3'), silylation can occur at either position, yielding **two products**: **2'-O-TBDMS** and **3'-O-TBDMS**.

3. **COSY NMR Analysis of Product 1**:
   - The COSY spectrum shows:
     - A **1H doublet at ~6 ppm (Ha)** correlates with a **1H doublet-of-doublets at ~4.5 ppm (Hb)**.
     - **Hb** also correlates with a **broad singlet at ~5.5 ppm**.
     - **Hb** correlates with **another 1H doublet-of-doublets at ~4.5 ppm (Hc)**.
   - These correlations are characteristic of **2'-O-TBDMS**-protected ribonucleosides. Specifically:
     - **Hb** corresponds to **H3'** (the proton on the 3' carbon).
     - **Hc** corresponds to **H2'** (the proton on the 2' carbon).
     - **Ha** is likely **H1'** (the anomeric proton), which is a doublet due to coupling with H2'.
     - The **broad singlet at ~5.5 ppm** is likely **H1'** in a slightly exchangeable state (common in silylated systems).
   - This pattern confirms that **product 1 is the 2'-O-TBDMS derivative**, not the 3'-O-TBDMS derivative (which would show different coupling patterns).

4. **Synthesis of RNA Oligo**:
   - Product 1 (2'-O-TBDMS) is converted into a **phosphoramidite** using 2-cyanoethyl N,N-diisopropylchlorophosphoramidite.
   - This phosphoramidite is then used in **solid-phase RNA synthesis**.
   - In standard RNA synthesis, the **TBDMS group is removed** after the oligo is fully synthesized (typically via acid hydrolysis), revealing the **free 2' OH**.

5. **Comparison with Natural RNA**:
   - The **naturally occurring RNA** has **free 2' OH groups** and is composed of **β-D-ribofuranose** sugars.
   - The **synthetic RNA** is made from a **β-D-ribonucleoside**, with the **2' OH protected as TBDMS** during synthesis (to prevent side reactions), but **deprotected after synthesis** to yield **free 2' OH**.
   - Since the **sugar stereochemistry** (β-D-ribo) is preserved throughout the process, and the **2' OH is restored** to its natural state, the **final synthetic RNA is identical** to the naturally occurring RNA with the same base sequence and sugar configuration.

---

### Why Not Other Options?

- **(A) Diastereoisomers**: This would require a **difference in stereochemistry** at a chiral center. However, the starting material is **β-D-ribonucleoside**, and silylation does **not alter** the stereochemistry of the sugar. Thus, no diastereoisomerism occurs.
  
- **(C) Constitutional isomers, but not regioisomers**: This would imply a **different connectivity** of atoms. But the synthetic RNA has the **same connectivity** as natural RNA (same sugar structure, same base sequence), so this is incorrect.
  
- **(D) Regioisomers**: This would imply a **difference in the position of a functional group** (e.g., 2' vs 3' protection). However, the **TBDMS group is removed** after synthesis, so the final product has the **same regiochemistry** as natural RNA.

---

### Final Answer:

Final answer: (B)
```

## Full generated reasoning and answer

```text
Okay, let's try to work through this problem step by step. Hmm, so the chemist is making an RNA nucleoside phosphoramidite from a β-D-ribonucleoside. First, they install DMTr on the 5'-OH. Then they treat with 1.1 equivalents of TBDMSCl, which gives two products (1 and 2). They isolate both and take COSY NMR for each.

The key part is the COSY spectrum of product 1. The features are:

- Correlation between Ha (6 ppm, doublet) and Hb (4.5 ppm, doublet-of-doublets)
- Hb correlates with a broad singlet at 5.5 ppm
- Hb correlates with Hc (another 4.5 ppm, doublet-of-doublets)

Wait, TBDMSCl is tert-butyldimethylsilyl chloride, right? So it's used for silylation of OH groups. Since they're treating the 5'-ODMTr ribonucleoside (so 5' has DMTr), TBDMSCl would silylate the other hydroxyl groups. But in a ribonucleoside, there are three hydroxyls: 2', 3', and 5' (but 5' is protected with DMTr here). Wait, no: the nucleoside has a sugar with 2' and 3' OHs. Wait, the starting material is a β-D-ribonucleoside, so the sugar is ribose, which has 2' OH and 3' OH, and the 5' is a CH2OH (but in nucleosides, the 5' is usually OH unless modified). Wait, no: nucleosides are base + sugar. The ribose sugar in RNA has 2' OH, 3' OH, and 5' CH2OH? Wait, no: in RNA, the ribose is a 5-membered ring with C1' attached to the base, C2' OH, C3' OH, C4' connected to C5', and C5' is CH2OH? Wait, no: in standard ribose (as in RNA), the 5' carbon is part of the ring? Wait, no, ribose is a 5-carbon sugar (pentose) where C1' is the anomeric carbon attached to the base. So the structure is:

C1' (attached to base) - C2' (OH) - C3' (OH) - C4' - C5' (CH2OH)

So in a ribonucleoside (not nucleotide), the 5' position is CH2OH, so it's a primary alcohol. But in this problem, the starting material is a β-D-ribonucleoside. Wait, the chemist first installs DMTr on the 5'-OH. So the 5' OH here is the CH2OH group's OH? Wait, no: in nucleosides, the 5' carbon (C5') is part of the chain. Wait, I'm getting confused here.

Let me recall: In RNA nucleosides (e.g., adenosine), the ribose sugar has the following structure: the base is attached at the anomeric carbon (C1'), which is a chiral center. The sugar is a furanose ring, so C1' is connected to C2', which is connected to C3', then C4' connected to C5', and C5' is CH2OH. So the 5' hydroxyl is on C5' (a primary alcohol), yes. So the 5' OH is the primary alcohol at C5'.

So the starting material is a β-D-ribonucleoside, so the 5' OH is free (but they install DMTr on it first). Wait, the problem says: "First, they install the DMTr protecting group on the 5'-OH." So the starting ribonucleoside has a 5' OH (primary), which they protect with DMTr.

Then, they treat the 5'-ODMTr ribonucleoside with 1.1 eq of TBDMSCl. TBDMSCl is a silylating agent (tert-butyldimethylsilyl chloride), so it will react with hydroxyl groups. The nucleoside has two other hydroxyls: the 2' OH and 3' OH (since 5' is protected with DMTr). So TBDMSCl should silylate either the 2' or 3' OH.

But the problem says two products are formed (products 1 and 2). So silylation can happen at 2' or 3' positions, leading to two different silylated products.

So product 1 and product 2 are the 2'-O-TBDMS and 3'-O-TBDMS derivatives.

Now, they take product 1 (the one they keep) and do COSY NMR.

The COSY spectrum features:

- Ha (6 ppm, doublet) correlates with Hb (4.5 ppm, doublet-of-doublets)
- Hb correlates with a broad singlet at 5.5 ppm
- Hb correlates with Hc (another 4.5 ppm, doublet-of-doublets)

Let's think about the proton NMR signals.

In ribose, the protons are:

- H1' (attached to C1', which is the anomeric carbon; in β-D-ribo, it's usually a specific configuration)
- H2' (on C2')
- H3' (on C3')
- H4' (on C4')
- H5' (the CH2 group, so two protons: H5a and H5b)

But the 5' is protected with DMTr (so the CH2OH group is now CH2-O-DmTr), so the H5' protons would be the CH2 group.

Wait, in the nucleoside, the 5' carbon (C5') is CH2OH, so after DMTr protection, it's CH2-O-DmTr. So the protons on C5' (H5a and H5b) would be a doublet (since they are attached to CH2-O), but in the problem, Ha is a doublet at ~6 ppm. Wait, 6 ppm is a bit high for aliphatic protons. Maybe Ha is the anomeric proton (H1')?

In nucleosides, the anomeric proton (H1') can be around 4-5 ppm, but maybe in some cases it's shifted. Wait, but in RNA, the 2' OH is present, so the sugar is in the furanose form.

Wait, let's try to map the signals.

First, in a ribose sugar, the protons:

- H1' (C1'): in β-D-ribo, the H1' is a proton on the anomeric carbon. In the furanose ring, H1' is usually a doublet (coupling to H2').

- H2' (C2'): a proton on C2', which is a chiral center. In ribose, H2' is a doublet of doublets (coupling to H1' and H3').

- H3' (C3'): similar, doublet of doublets.

- H4' (C4'): in the furanose ring, H4' is a doublet (coupling to H3' and H5').

- H5' (C5'): CH2 group (since C5' is CH2OH), so two protons (H5a and H5b), which are a doublet (coupling to H4').

But in the problem, after silylation, the 2' or 3' OH is protected with TBDMS. So the silyl group is on O2' or O3'.

Let's think about the COSY correlations.

COSY shows correlations between protons that are coupled (through 3 bonds).

Product 1's COSY:

- Ha (6 ppm, doublet) correlates with Hb (4.5 ppm, doublet-of-doublets)

So Ha and Hb are coupled (3J). Ha is a doublet (so it's coupled to one proton), Hb is doublet-of-doublets (coupled to two protons).

The broad singlet at 5.5 ppm is probably a proton that's not coupled (or has a broad peak due to exchange), like an OH proton. Wait, but they silylated the OHs, so the TBDMS group would protect the OH, so the OH protons might not be present. Wait, TBDMSCl is used to silylate the hydroxyls, so the OH becomes O-TBDMS. So the protons in the TBDMS group are the tert-butyl protons (which are usually singlets around 1-2 ppm), but the problem mentions a broad singlet at 5.5 ppm. Hmm.

Wait, the broad singlet at 5.5 ppm could be the proton of the silylated hydroxyl? No, silylation replaces the OH with O-TBDMS, so the proton is gone. Wait, maybe the 5.5 ppm singlet is the anomeric proton (H1')? In some cases, the anomeric proton can be around 5-6 ppm, but the problem says Ha is a doublet at 6 ppm.

Wait, let's try to think differently. In the ribose sugar, the 2' and 3' protons are adjacent, so they might have coupling.

If product 1 is the 2'-O-TBDMS derivative, then the 2' OH is protected, so the 2' proton (H2') is now a methine proton (attached to C2') with no OH, so it might have different coupling.

Wait, the COSY has Hb correlating with a broad singlet at 5.5 ppm. A broad singlet at 5.5 ppm is often a proton that's exchanging (like an OH), but in the silylated product, the OH is protected, so maybe the broad singlet is the 1' proton (H1')? Wait, H1' in ribose can be around 4-5 ppm. Hmm.

Alternatively, the broad singlet at 5.5 ppm could be a proton that's part of the TBDMS group? No, TBDMS is a bulky group; the tert-butyl protons are usually singlets around 1.3 ppm.

Wait, another thought: in RNA nucleotides, the 2' OH is important for the structure. If they silylated the 2' OH, then the 2' proton (H2') would be a methine proton with a different chemical shift.

Let's try to map the signals.

Assume product 1 is the 2'-O-TBDMS derivative.

In the 2'-O-TBDMS ribonucleoside:

- H1' (anomeric proton): in β-D-ribo, H1' is a doublet (J ~ 5-7 Hz) around 4-5 ppm? Wait, but in the problem, Ha is a doublet at 6 ppm. Hmm.

Wait, maybe Ha is the H5' protons? No, H5' (CH2) would be around 3-4 ppm.

Wait, another angle: in the problem, they take product 1 (the one with the specific COSY) and proceed to make the phosphoramidite. Then they synthesize RNA oligo with standard solid-phase.

The question is: compare their synthetic RNA oligo with a naturally occurring RNA oligo with same bases and sequence. What's the relationship?

The options are diastereomers, identical, constitutional isomers, regioisomers.

The key here is the stereochemistry of the sugar.

In natural RNA, the ribose is β-D-ribo (i.e., the anomeric carbon has the base on the opposite side of the ring, with the 2' OH in the same orientation as in β-D-ribofuranose).

When they synthesize the phosphoramidite, they're using a nucleoside with 2'-O-TBDMS (product 1) or 3'-O-TBDMS (product 2). Wait, but the problem says they discard product 2 and take product 1 through to the phosphoramidite.

The key is: in the natural RNA, the 2' OH is present (not protected), but here they have a silylated 2' OH (TBDMS). Wait, no: in the synthesis of RNA oligos via phosphoramidite method, the nucleosides are protected at 2' and 3' (but in RNA, the 2' OH is present, so they don't protect it in the final RNA). Wait, no: in solid-phase RNA synthesis, they use nucleoside phosphoramidites that have 2' OH protected (to prevent side reactions), but the final RNA has 2' OH.

Wait, no: standard RNA synthesis uses phosphoramidites with 2'-OH protected (e.g., with TBDMS) to prevent 2' nucleophilic attack during coupling. Wait, no, in RNA synthesis, the 2' OH is present in the final RNA, but during synthesis, the nucleosides are protected at 2' (with TBDMS) to avoid side reactions. Wait, maybe I'm confused here.

Wait, in the problem: they start with a β-D-ribonucleoside (so the sugar has 2' OH and 3' OH). They install DMTr on 5' OH (so 5' is protected), then treat with TBDMSCl (1.1 eq) to silylate 2' or 3' OH.

Product 1 and 2 are 2'-O-TBDMS and 3'-O-TBDMS.

They take product 1 (the one with the specific COSY) and proceed to phosphoramidite.

The key is: what's the difference between product 1 and product 2?

If product 1 is 2'-O-TBDMS, then when they make the phosphoramidite, the 2' OH is protected with TBDMS. But in natural RNA, the 2' OH is free (not protected). Wait, but in the final RNA oligo they synthesize, they would deprotect the TBDMS group (since TBDMS is a temporary protecting group), right?

Wait, the problem says: "they take product 1 through to the final nucleoside phosphoramidite by treating it with 2-cyanoethyl N,N-diisopropylchlorophosphoramidite". So the phosphoramidite is made with the 2'-O-TBDMS group still present.

Then they synthesize the RNA oligo using standard solid-phase methodology. In standard solid-phase RNA synthesis, the TBDMS group is used as a protecting group for the 2' OH, which is then removed after synthesis to give the RNA with 2' OH.

But the question says: compare their synthetic RNA oligo with a naturally occurring RNA oligo with exactly the same types and sequence of bases.

Wait, "naturally occurring RNA" has 2' OH groups (not protected), so if their synthetic RNA has TBDMS on the 2' OH (which is removed after synthesis), then it would be identical.

Wait, but the problem states that they "use this phosphoramidite to synthesize an RNA oligo using standard solid-phase methodology". In standard RNA synthesis, the TBDMS is removed after synthesis (for example, with acid), so the final RNA would have free 2' OH.

But wait, in the synthesis steps:

1. They have the nucleoside phosphoramidite with 2'-O-TBDMS (product 1's phosphoramidite)
2. They couple this to the growing chain on solid support (using phosphoramidite chemistry)
3. After the oligo is built, they deprotect the TBDMS groups (to get the 2' OH) to get the RNA.

But the problem says: "they compare their synthetic RNA oligo with a naturally occurring RNA oligo with exactly the same types and sequence of bases". So the synthetic one would have been deprotected (so same as natural RNA).

Wait, but maybe not. Wait, the question is a bit tricky.

Wait, the key is: the starting material is β-D-ribonucleoside (so the sugar has the correct stereochemistry for RNA). When they silylate 2' or 3' OH, the stereochemistry of the sugar is still the same (since they're just protecting the OH), so the stereochemistry of the sugar is preserved.

But the problem is about the relationship between their synthetic RNA and natural RNA.

Wait, another angle: in the COSY spectrum of product 1, the correlations indicate that Hb is coupled to Ha and Hc. If Hb is the 2' proton, and Hc is the 3' proton (since they are adjacent), then the COSY shows coupling between 2' and 3' protons. But in a ribose sugar, the 2' and 3' protons are both in the ring and should be coupled.

Wait, the COSY of product 1 has Hb correlating with two different protons (Hc and Ha). Wait, no: the problem says "a correlation between Hb and another 1H doublet-of-doublets at approx. 4.5 ppm (Hc)". So Hb is correlated with Ha and Hc.

Wait, Ha is a doublet at 6 ppm (so one coupling partner), Hb is doublet-of-doublets (two coupling partners), Hc is another doublet-of-doublets at 4.5 ppm.

In ribose, the protons are:

- H1' (anomeric): around 4-5 ppm (doublet)
- H2' (C2'): around 3-4 ppm (doublet of doublets)
- H3' (C3'): around 3-4 ppm (doublet of doublets)
- H4' (C4'): around 3-4 ppm (doublet)
- H5' (CH2): around 3.5-4 ppm (doublet)

But in the problem, product 1 has a COSY where Hb (4.5 ppm) correlates with Ha (6 ppm, doublet) and Hc (4.5 ppm, doublet-of-doublets). So Hb and Hc are two different protons both at 4.5 ppm (doublet-of-doublets), which suggests they are adjacent protons (like H2' and H3').

In the ribose ring, the 2' and 3' protons are adjacent (3J), so they should have a COSY correlation. So if product 1 is the 2'-O-TBDMS derivative, then H2' (which is now a methine proton) would be coupled to H1' and H3'. But in the COSY, Hb correlates with Ha (6 ppm) and Hc (4.5 ppm). So maybe Hb is H3' (4.5 ppm), Hc is H2' (4.5 ppm), and Ha is H1' (6 ppm)?

Wait, H1' is usually around 4-5 ppm, not 6 ppm. Hmm.

Alternatively, Ha is the proton of the TBDMS group? No, TBDMS protons are at ~1.3 ppm.

Wait, the broad singlet at 5.5 ppm is probably the 1' proton (H1') which is exchanging (but in a silylated product, the OH is protected, so maybe it's not exchanging). Or it's the 2' proton? Not sure.

Let's try to focus on the main point: the relationship between the synthetic RNA and natural RNA.

The problem states that they started with a β-D-ribonucleoside. So the sugar is already in the β-D configuration (which is the natural one for RNA). Then, they protect the 5' OH with DMTr, silylate either 2' or 3' OH. They take product 1 (the one with specific COSY) and go through to make the phosphoramidite.

The key is: in the natural RNA, the 2' OH is present (not protected), whereas in the synthetic RNA, during synthesis they have the 2' OH protected with TBDMS (product 1 is 2'-O-TBDMS), but after synthesis, they remove the TBDMS group (standard protocol), so the final RNA would have free 2' OH. Therefore, the synthetic RNA would be identical to natural RNA.

But wait, the question says: "they compare their synthetic RNA oligo with a naturally occurring RNA oligo with exactly the same types and sequence of bases". So if the synthetic RNA has the same sequence and bases, and the TBDMS is removed (as it's standard), then they should be identical.

But the problem might be about stereochemistry. Wait, another angle: the ribose in natural RNA is β-D-ribo, but if they silylate the 2' OH, does that affect stereochemistry? No, silylation doesn't change stereochemistry.

Wait, but the problem says "they discard product 2 and take product 1". Product 2 is the 3'-O-TBDMS derivative. Product 1 is the 2'-O-TBDMS.

If they used 2'-O-TBDMS, then after deprotection, it's the same as natural RNA.

But why is the COSY spectrum important here? The COSY features indicate that product 1 has a specific coupling pattern, which would be characteristic of the 2'-O-TBDMS derivative.

For example, in 2'-O-TBDMS ribonucleosides, the 2' proton (H2') is a doublet-of-doublets (coupled to H1' and H3'), and the 3' proton (H3') is also a doublet-of-doublets (coupled to H2' and H4').

The broad singlet at 5.5 ppm might be H1' (anomeric proton), which in some cases can be a broad singlet due to exchange (but in silylated products, it's less likely).

Assuming that product 1 is the 2'-O-TBDMS derivative (since they discarded product 2), then when they make the phosphoramidite and synthesize the RNA, they deprotect the TBDMS group (standard procedure), so the final RNA has free 2' OH, same as natural RNA.

Thus, the synthetic RNA would be identical to natural RNA.

Wait, but option B is "Identical".

But wait, another thought: in RNA synthesis, the nucleotides are added with 3' OH (not protected), but here they're protecting the 2' OH. But in the final product, the 2' OH is deprotected, so it's the same.

But wait, the problem states: "naturally occurring RNA oligo with exactly the same types and sequence of bases". So the synthetic RNA would have the same sequence, same base types, same sugar (β-D-ribo), so identical.

But why is the COSY spectrum given? Maybe to determine whether product 1 is 2'-O-TBDMS or 3'-O-TBDMS.

If product 1 is 2'-O-TBDMS, then the 2' OH is protected, so the 2' proton is a methine proton (no exchange), and the coupling pattern would show H2' coupled to H1' and H3'.

In the COSY, Hb (4.5 ppm, doublet-of-doublets) correlates with Ha (6 ppm, doublet) and Hc (4.5 ppm, doublet-of-doublets). So Hb is coupled to two protons: Ha and Hc.

If Ha is H1' (anomeric), and Hc is H2', then Hb (H3') would be coupled to H2' (Hc) and H4' (which might be a different proton).

But the problem states that Hb correlates with a broad singlet at 5.5 ppm. Maybe that broad singlet is the H1' proton (which is exchanging, hence broad), but in a silylated product, it's less likely.

Alternatively, the broad singlet at 5.5 ppm is the 3' OH proton (but they silylated it, so it's gone).

Hmm, this is tricky.

Let's try to think about the answer choices.

The options are:

(A) Diastereoisomers

(B) Identical

(C) Constitutional isomers, but not regioisomers

(D) Regioisomers

Diastereomers would occur if there's a chiral center with different configuration.

In RNA, the ribose is β-D-ribo, which is a specific stereoisomer. If the synthesis uses the correct stereoisomer (β-D-ribonucleoside), then the synthetic RNA should be identical.

The key here is that the silylation step (2' or 3') doesn't change the stereochemistry of the sugar. They started with β-D-ribonucleoside (so the sugar has the correct stereochemistry), and protecting the 2' OH with TBDMS doesn't alter the stereochemistry. So the synthetic RNA, after deprotection, would have the same stereochemistry as natural RNA.

Therefore, the answer should be (B) Identical.

But wait, why would the COSY spectrum matter? The problem says they discard product 2 and take product 1. The COSY features indicate that product 1 is the 2'-O-TBDMS derivative (not 3'-O-TBDMS). Because in 3'-O-TBDMS, the coupling patterns would be different.

For example, in 3'-O-TBDMS, the 3' proton (H3') is protected, so H3' would have different coupling. The COSY correlations in product 1 suggest that Hb is coupled to two protons (Ha and Hc), which are likely H1' and H2' (if it's 2'-O-TBDMS), whereas in 3'-O-TBDMS, the coupling might be different.

Assuming product 1 is the 2'-O-TBDMS derivative (which is the correct one for RNA synthesis), then after deprotection, the RNA is identical.

But in RNA synthesis, the 2' OH is protected during synthesis to prevent side reactions, but after synthesis, it's deprotected. So the final product has 2' OH, same as natural RNA.

Therefore, the synthetic RNA is identical to natural RNA.

So the answer is B.

Wait, but another angle: in the problem statement, they "synthesize an RNA nucleoside phosphoramidite from a β-D-ribonucleoside". The phosphoramidite is made with the 2' OH protected (TBDMS). Then they synthesize the RNA oligo. In standard RNA synthesis, the TBDMS is removed after synthesis, so the final RNA has free 2' OH. So it's identical.

Yes, so answer is B.

But why is the COSY spectrum given? To confirm that product 1 is the 2'-O-TBDMS (which is the correct one for RNA synthesis, as 3'-O-TBDMS would not be used in RNA synthesis because it's not the typical protecting group for 2' OH).

In RNA synthesis, the 2' OH is protected (with TBDMS), so they need the 2'-O-TBDMS derivative. Product 2 is 3'-O-TBDMS, which is not used in RNA synthesis (since it's the 2' OH that's protected in RNA synthesis), so they discard product 2 and use product 1 (2'-O-TBDMS).

Therefore, the synthetic RNA is identical to natural RNA.

So answer is B.
</think>

The problem involves the synthesis of an RNA nucleoside phosphoramidite from a β-D-ribonucleoside. The key steps and the NMR data provided are critical to understanding the stereochemistry and structure of the final product.

---

### Step-by-Step Reasoning:

1. **Starting Material**: The chemist begins with a **β-D-ribonucleoside**, which is the natural configuration of the ribose sugar in RNA. This means the sugar has the correct stereochemistry for RNA (i.e., the anomeric carbon is in the β configuration, and the 2' OH is present in the equatorial position in the furanose ring).

2. **Protection Steps**:
   - First, the **5'-OH** is protected with **DMTr** (dimethoxytrityl).
   - Then, **TBDMSCl** (tert-butyldimethylsilyl chloride) is added in 1.1 equivalents. This reagent silylates the hydroxyl groups on the ribose sugar.
   - Since the ribose has two free hydroxyls (2' and 3'), silylation can occur at either position, yielding **two products**: **2'-O-TBDMS** and **3'-O-TBDMS**.

3. **COSY NMR Analysis of Product 1**:
   - The COSY spectrum shows:
     - A **1H doublet at ~6 ppm (Ha)** correlates with a **1H doublet-of-doublets at ~4.5 ppm (Hb)**.
     - **Hb** also correlates with a **broad singlet at ~5.5 ppm**.
     - **Hb** correlates with **another 1H doublet-of-doublets at ~4.5 ppm (Hc)**.
   - These correlations are characteristic of **2'-O-TBDMS**-protected ribonucleosides. Specifically:
     - **Hb** corresponds to **H3'** (the proton on the 3' carbon).
     - **Hc** corresponds to **H2'** (the proton on the 2' carbon).
     - **Ha** is likely **H1'** (the anomeric proton), which is a doublet due to coupling with H2'.
     - The **broad singlet at ~5.5 ppm** is likely **H1'** in a slightly exchangeable state (common in silylated systems).
   - This pattern confirms that **product 1 is the 2'-O-TBDMS derivative**, not the 3'-O-TBDMS derivative (which would show different coupling patterns).

4. **Synthesis of RNA Oligo**:
   - Product 1 (2'-O-TBDMS) is converted into a **phosphoramidite** using 2-cyanoethyl N,N-diisopropylchlorophosphoramidite.
   - This phosphoramidite is then used in **solid-phase RNA synthesis**.
   - In standard RNA synthesis, the **TBDMS group is removed** after the oligo is fully synthesized (typically via acid hydrolysis), revealing the **free 2' OH**.

5. **Comparison with Natural RNA**:
   - The **naturally occurring RNA** has **free 2' OH groups** and is composed of **β-D-ribofuranose** sugars.
   - The **synthetic RNA** is made from a **β-D-ribonucleoside**, with the **2' OH protected as TBDMS** during synthesis (to prevent side reactions), but **deprotected after synthesis** to yield **free 2' OH**.
   - Since the **sugar stereochemistry** (β-D-ribo) is preserved throughout the process, and the **2' OH is restored** to its natural state, the **final synthetic RNA is identical** to the naturally occurring RNA with the same base sequence and sugar configuration.

---

### Why Not Other Options?

- **(A) Diastereoisomers**: This would require a **difference in stereochemistry** at a chiral center. However, the starting material is **β-D-ribonucleoside**, and silylation does **not alter** the stereochemistry of the sugar. Thus, no diastereoisomerism occurs.
  
- **(C) Constitutional isomers, but not regioisomers**: This would imply a **different connectivity** of atoms. But the synthetic RNA has the **same connectivity** as natural RNA (same sugar structure, same base sequence), so this is incorrect.
  
- **(D) Regioisomers**: This would imply a **difference in the position of a functional group** (e.g., 2' vs 3' protection). However, the **TBDMS group is removed** after synthesis, so the final product has the **same regiochemistry** as natural RNA.

---

### Final Answer:

Final answer: (B)
```

## Explored branch continuations

Alternatives below were explored; only the selected rollout was committed. Their presence does not establish the cause of the error.

### Body position 6

Selected (rank 1):

```text
 work through this problem step by step. Hmm, so the chemist is making an RNA nucleoside phosphoramidite from a β-D-ribonucleoside. First, they install DMTr on the 5'-OH. Then they treat with 1.1 equivalents of TBDMSCl,
```

Unchosen (rank 2):

```text
 figure out this problem step by step. So, the chemist is making an RNA nucleoside phosphoramidite from a β-D-ribonucleoside. The process involves adding a DMTr group on the 5'-OH first, then treating with TBDMSCl (which I think is tert
```

### Body position 271

Selected (rank 1):

```text
' (but 5' is protected with DMTr here). Wait, no: the nucleoside has a sugar with 2' and 3' OHs. Wait, the starting material is a β-D-ribonucleoside, so the sugar is ribose, which has 2' OH
```

Unchosen (rank 2):

```text
'. Wait, no: in a ribonucleoside (like adenosine), the structure is a sugar (ribose) with a base attached at C1'. The 5' position has an OH (if it's a nucleoside, not nucleotide), but here they started with a β-D
```

### Body position 530

Selected (rank 1):

```text
 (OH) - C3' (OH) - C4' - C5' (CH2OH)

So in a ribonucleoside (not nucleotide), the 5' position is CH2OH, so it's a primary alcohol. But in this problem, the starting material is a β
```

Unchosen (rank 2):

```text
 - C3' - C4' - C5' (CH2OH)

Wait, yes, in ribose (in nucleosides), the 5' carbon has a CH2OH group (so 5' hydroxyl is on C5'). Wait, no: in the ribose sugar,
```

### Body position 787

Selected (rank 1):

```text
 C5'.

So the starting material is a β-D-ribonucleoside, so the 5' OH is free (but they install DMTr on it first). Wait, the problem says: "First, they install the DMTr protecting group on the 5'-OH." So the starting ribon
```

Unchosen (rank 2):

```text
 the end of the chain (C5'-CH2OH).

Wait, but in the problem statement: "they install the DMTr protecting group on the 5'-OH". So the 5'-OH is the primary alcohol (C5' OH), so DMTr is installed there. Then they treat with TB
```

### Body position 1055

Selected (rank 1):

```text
 they take product 1 (the one they keep) and do COSY NMR.

The COSY spectrum features:

- Ha (6 ppm, doublet) correlates with Hb (4.5 ppm, doublet-of-doublets)
- Hb correlates with a broad singlet at 5.5 ppm
```

Unchosen (rank 2):

```text
 the COSY spectrum of product 1 shows:

- Ha (6 ppm, doublet) and Hb (4.5 ppm, doublet-of-doublets) correlate.

- Hb correlates with a broad singlet at 5.5 ppm.

- Hb correlates with Hc (another 4.
```

### Body position 1313

Selected (rank 1):

```text
-O-DmTr. So the protons on C5' (H5a and H5b) would be a doublet (since they are attached to CH2-O), but in the problem, Ha is a doublet at ~6 ppm. Wait, 6 ppm is a bit high for aliph
```

Unchosen (rank 2):

```text
-ODMTr. So the protons at C5' would be a doublet (since CH2 next to O).

But the problem states that Ha is a doublet at ~6 ppm. That's a bit high. Wait, 6 ppm is typical for protons attached to an aromatic ring or maybe
```

### Body position 1577

Selected (rank 1):

```text
 similar, doublet of doublets.

- H4' (C4'): in the furanose ring, H4' is a doublet (coupling to H3' and H5').

- H5' (C5'): CH2 group (since C5' is CH2OH), so
```

Unchosen (rank 2):

```text
 similarly, doublet of doublets.

- H4' (C4'): a proton that might be a doublet (coupling to H3' and H5').

- H5' (C5'): the CH2 group (two protons), which would be a doublet (coupling to H
```

### Body position 1833

Selected (rank 1):

```text
 like an OH proton. Wait, but they silylated the OHs, so the TBDMS group would protect the OH, so the OH protons might not be present. Wait, TBDMSCl is used to silylate the hydroxyls, so the OH becomes O-TBDMS. So
```

Unchosen (rank 2):

```text
 which might be the silylated proton? Wait, TBDMS is a silyl ether, so the TBDMS group is attached to oxygen. The protons on the TBDMS group would be the tert-butyl group (nine protons), but in TBDMSCl, it's tert-butyldim
```

### Body position 2096

Selected (rank 1):

```text
, so the 2' proton (H2') is now a methine proton (attached to C2') with no OH, so it might have different coupling.

Wait, the COSY has Hb correlating with a broad singlet at 5.5 ppm. A broad singlet at 5.
```

Unchosen (rank 2):

```text
. In that case, the 2' proton (H2') would not be exchanging and might have a different coupling.

But the problem states that product 1 has a correlation between Ha (6 ppm, doublet) and Hb (4.5 ppm, doublet-of-doublets), and Hb correlates
```

### Body position 2354

Selected (rank 1):

```text
 the 2'-O-TBDMS ribonucleoside:

- H1' (anomeric proton): in β-D-ribo, H1' is a doublet (J ~ 5-7 Hz) around 4-5 ppm? Wait, but in the problem, Ha is a
```

Unchosen (rank 2):

```text
 this case, the 2' OH is protected, so the H2' proton is now a proton on a carbon with no OH (so it's a methine proton). In the ribose ring, H2' is coupled to H1' and H3'.

So in COSY, H2' (
```

### Body position 2612

Selected (rank 1):

```text
).

When they synthesize the phosphoramidite, they're using a nucleoside with 2'-O-TBDMS (product 1) or 3'-O-TBDMS (product 2). Wait, but the problem says they discard product 2 and take product 1 through to the phosph
```

Unchosen (rank 2):

```text
). But in the synthesis here, they start with β-D-ribonucleoside, so the sugar is already in the β configuration.

Wait, but the problem says "they install the DMTr protecting group on the 5'-OH". So the starting material is β-D-ribonucleoside,
```

### Body position 2870

Unchosen (rank 1):

```text
 nucleoside, but they protect it temporarily to avoid side reactions. Wait, perhaps this is getting too detailed.

Wait, the critical part is the stereochemistry of the sugar. Natural RNA has β-D-ribo sugars (the 2' OH is in the equatorial position in the furanose ring).


```

Selected (rank 2):

```text
 final RNA, but during synthesis, the nucleosides are protected at 2' (with TBDMS) to avoid side reactions. Wait, maybe I'm confused here.

Wait, in the problem: they start with a β-D-ribonucleoside (so the sugar has 2' OH and 
```

### Body position 3128

Selected (rank 1):

```text
 the problem says: "they take product 1 through to the final nucleoside phosphoramidite by treating it with 2-cyanoethyl N,N-diisopropylchlorophosphoramidite". So the phosphoramidite is made with the 2'-O-TBDMS group still
```

Unchosen (rank 2):

```text
 no: in solid-phase RNA synthesis, the standard method uses nucleoside phosphoramidites with 2'-OH protected (e.g., with TBDMS) to prevent the 2' OH from reacting with the incoming phosphoramidite. After the oligo is synthesized, the TBDMS groups are removed (
```

### Body position 3385

Unchosen (rank 1):

```text
 problem, they might have not removed the TBDMS group? Hmm, the problem says "synthetic RNA oligo" made via standard solid-phase. Let me check.

Standard RNA solid-phase synthesis uses nucleoside phosphoramidites with 2'-OH protected (e.g., TBDMS) to prevent side reactions
```

Selected (rank 2):

```text
 synthesis steps:

1. They have the nucleoside phosphoramidite with 2'-O-TBDMS (product 1's phosphoramidite)
2. They couple this to the growing chain on solid support (using phosphoramidite chemistry)
3. After the oligo is built, they de
```

### Body position 3641

Selected (rank 1):

```text
 Ha and Hc. If Hb is the 2' proton, and Hc is the 3' proton (since they are adjacent), then the COSY shows coupling between 2' and 3' protons. But in a ribose sugar, the 2' and 3' protons
```

Unchosen (rank 2):

```text
 two different protons (doublet-of-doublets), and Ha is a doublet (so one coupling partner). The broad singlet at 5.5 ppm might be the 1' proton (H1') which is exchanging (but in reality, in silylated products, the OH is protected so exchange
```

### Body position 3912

Selected (rank 1):

```text
3-4 ppm (doublet)
- H5' (CH2): around 3.5-4 ppm (doublet)

But in the problem, product 1 has a COSY where Hb (4.5 ppm) correlates with Ha (6 ppm, doublet) and Hc (4
```

Unchosen (rank 2):

```text
4-5 ppm (doublet)
- H5' (C5' CH2): around 3-4 ppm (doublet)

But the problem's Ha is at 6 ppm (higher than usual), so maybe Ha is the anomeric proton in a different conformation.

Wait, if product 1
```

### Body position 4173

Unchosen (rank 1):

```text
 but if it's a doublet at 6 ppm, maybe it's a different situation.

Alternatively, the broad singlet at 5.5 ppm could be the 2' OH proton (but it's silylated, so no). Wait, the broad singlet might be due to the 2'
```

Selected (rank 2):

```text
 not 6 ppm. Hmm.

Alternatively, Ha is the proton of the TBDMS group? No, TBDMS protons are at ~1.3 ppm.

Wait, the broad singlet at 5.5 ppm is probably the 1' proton (H1') which is exchanging (but in a s
```

### Body position 4432

Selected (rank 1):

```text
 group (standard protocol), so the final RNA would have free 2' OH. Therefore, the synthetic RNA would be identical to natural RNA.

But wait, the question says: "they compare their synthetic RNA oligo with a naturally occurring RNA oligo with exactly the same types and sequence of bases". So if the
```

Unchosen (rank 2):

```text
 to get the RNA with free 2' OH.

Wait, but the problem says "they compare their synthetic RNA oligo with a naturally occurring RNA oligo". If the synthetic RNA has been deprotected (so has free 2' OH), then it's identical to natural RNA.

But the problem says "ex
```

### Body position 4688

Selected (rank 1):

```text
.

For example, in 2'-O-TBDMS ribonucleosides, the 2' proton (H2') is a doublet-of-doublets (coupled to H1' and H3'), and the 3' proton (H3') is also a doublet-of-doublets (
```

Unchosen (rank 2):

```text
 (since 2' and 3' protons are coupled).

Wait, in the COSY of product 1:

- Hb correlates with Ha (6 ppm) and Hc (4.5 ppm). If Hb is H3' (4.5 ppm), then H3' is coupled to
```

### Body position 4946

Selected (rank 1):

```text
 deprotected, so it's the same.

But wait, the problem states: "naturally occurring RNA oligo with exactly the same types and sequence of bases". So the synthetic RNA would have the same sequence, same base types, same sugar (β-D-ribo), so identical.

But why is the COS
```

Unchosen (rank 2):

```text
 present, so it's identical.

But the problem says "naturally occurring RNA oligo with exactly the same types and sequence of bases". So the synthetic one would have the same sequence, same bases, same 2' OH (after deprotection), so they're identical.

But why is the COSY spectrum
```

### Body position 5202

Selected (rank 1):

```text
 problem states that Hb correlates with a broad singlet at 5.5 ppm. Maybe that broad singlet is the H1' proton (which is exchanging, hence broad), but in a silylated product, it's less likely.

Alternatively, the broad singlet at 5.5 ppm is the
```

Unchosen (rank 2):

```text
 broad singlet at 5.5 ppm could be H1' (since in some cases, H1' is a broad singlet due to exchange).

If the 2' OH is protected (TBDMS), then the 2' proton (H2') is not exchanging, so its signal is sharp
```

### Body position 5462

Selected (rank 1):

```text
 alter the stereochemistry. So the synthetic RNA, after deprotection, would have the same stereochemistry as natural RNA.

Therefore, the answer should be (B) Identical.

But wait, why would the COSY spectrum matter? The problem says they discard product 2 and take product 1. The COS
```

Unchosen (rank 2):

```text
 affect the chirality.

So the synthetic RNA would have the same stereochemistry as natural RNA.

Therefore, the answer should be B) Identical.

Wait, but why is the COSY spectrum important here? To confirm that they used the correct silylation (product 1 is 2'-O-TBDMS
```

### Body position 5720

Selected (rank 1):

```text
 but after synthesis, it's deprotected. So the final product has 2' OH, same as natural RNA.

Therefore, the synthetic RNA is identical to natural RNA.

So the answer is B.

Wait, but another angle: in the problem statement, they "synthesize an RNA nucleoside phosphoramidite
```

Unchosen (rank 2):

```text
 so the final RNA after deprotection has the 2' OH free, same as natural RNA.

Therefore, the synthetic RNA is identical to natural RNA.

Wait, but the problem says "naturally occurring RNA oligo with exactly the same types and sequence of bases". So the synthetic RNA has the same sequence and
```

### Body position 5978

Selected (rank 1):

```text
 OH that's protected in RNA synthesis), so they discard product 2 and use product 1 (2'-O-TBDMS).

Therefore, the synthetic RNA is identical to natural RNA.

So answer is B.

```

Unchosen (rank 2):

```text
 that's protected), so they discard product 2 and take product 1 (2'-O-TBDMS).

Thus, the synthetic RNA is identical to natural RNA.

So the answer is B.

```

